Results 161 to 170 of about 35,812 (218)

LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer. [PDF]

open access: yesNeoplasia
Kumaraswamy A   +14 more
europepmc   +1 more source

Targeting endoplasmic reticulum stress and nitroso-redox imbalance in neuroendocrine prostate cancer: the therapeutic role of nitric oxide. [PDF]

open access: yesCell Death Discov
Firdaus F   +13 more
europepmc   +1 more source

Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer. [PDF]

open access: yesJ Exp Clin Cancer Res
Liu B   +18 more
europepmc   +1 more source

Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancer. [PDF]

open access: yesInt Cancer Conf J
Nakamura Y   +9 more
europepmc   +1 more source

New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic. [PDF]

open access: yesResearch (Wash D C)
Cai M   +9 more
europepmc   +1 more source

Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study. [PDF]

open access: yesClin Cancer Res
Aggarwal R   +18 more
europepmc   +1 more source

Impact of Metastatic Microenvironment on Physiology and Metabolism of Small Cell Neuroendocrine Prostate Cancer Patient-Derived Xenografts. [PDF]

open access: yesCancers (Basel)
Agarwal S   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy